Literature DB >> 9660998

Differences in the lipoprotein distribution of free and liposome-associated all-trans-retinoic acid in human, dog, and rat plasma are due to variations in lipoprotein lipid and protein content.

K M Wasan1, M Ramaswamy, S P Ng, W Wong, S C Parrott, J O Ojwang, T Wallace, P A Cossum.   

Abstract

The objective of the proposed study was to determine the distribution in plasma lipoprotein of free all-trans retinoic acid (ATRA) and liposomal ATRA (Atragen; composed of dimyristoyl phosphatidylcholine and soybean oil) following incubation in human, rat, and dog plasma. When ATRA and Atragen at concentrations of 1, 5, 10, and 25 micrograms/ml were incubated in human and rat plasma for 5, 60, and 180 min, the majority of the tretinoin was recovered in the lipoprotein-deficient plasma fraction. However, when ATRA and Afragen were incubated in dog plasma, the majority of the tretinoin (> 40%) was recovered in the high-density lipoprotein (HDL) fraction. No differences in the plasma distribution between ATRA and Atragen were found. These data suggest that a significant percentage of tretinoin associates with plasma lipoproteins (primarily the HDL fraction) upon incubation in human, dog, and rat plasma. Differences between the lipoprotein lipid and protein profiles in human plasma and in dog and rat plasma influenced the plasma distribution of ATRA and Atragen. Differences in lipoprotein distribution between ATRA and Atragen were not observed, suggesting that the drug's distribution in plasma in not influenced by its incorporation into these liposomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660998      PMCID: PMC105660     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  A comparison of step-gradient and sequential density ultracentrifugation and the use of lipoprotein deficient plasma controls in determining the plasma lipoprotein distribution of lipid-associated nystatin and cyclosporine.

Authors:  K M Wasan; S M Cassidy; M Ramaswamy; A Kennedy; F W Strobel; S P Ng; T Y Lee
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

2.  Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.

Authors:  M Lemaire; J P Tillement
Journal:  J Pharm Pharmacol       Date:  1982-11       Impact factor: 3.765

Review 3.  Beta blockers and lipoproteins: a review of current knowledge.

Authors:  R J Northcote; I C Todd; D Ballantyne
Journal:  Scott Med J       Date:  1986-10       Impact factor: 0.729

4.  High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia.

Authors:  J Nemunaitis; H J Deeg; G C Yee
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

5.  Influence of blood components on the tissue uptake indices of cyclosporin in rats.

Authors:  M Lemaire; W M Pardridge; G Chaudhuri
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

Review 6.  Plasma protein binding and therapeutic drug monitoring.

Authors:  M Rowland
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

7.  Interaction of plasma proteins and lipoproteins with amphotericin B.

Authors:  J Brajtburg; S Elberg; J Bolard; G S Kobayashi; R A Levy; R E Ostlund; D Schlessinger; G Medoff
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

8.  Involvement of binding lipoproteins in the absorption and transport of alpha-tocopherol in the rat.

Authors:  O V Rajaram; P Fatterpaker; A Sreenivasan
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

9.  Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits.

Authors:  M H Koldin; G S Kobayashi; J Brajtburg; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine.

Authors:  E Pike; B Skuterud; P Kierulf; P K Lunde
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

View more
  4 in total

Review 1.  Animal models for the atherosclerosis research: a review.

Authors:  Li Xiangdong; Liu Yuanwu; Zhang Hua; Ren Liming; Li Qiuyan; Li Ning
Journal:  Protein Cell       Date:  2011-04-06       Impact factor: 14.870

Review 2.  Conservation in the phylum of the local homology of apolipoproteins with the thyroid hormone plasma carriers.

Authors:  Salvatore Benvenga; Fabrizio Guarneri
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

3.  Sustained Drug Release From Liposomes for the Remodeling of Systemic Immune Homeostasis and the Tumor Microenvironment.

Authors:  Anjie Zheng; Fang Xie; Sanyuan Shi; Shounan Liu; Jinfeng Long; Yuhong Xu
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

4.  Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography.

Authors:  Hisashi Mizutani; Toshinori Sako; Hiroko Okuda; Nobuaki Arai; Koji Kuriyama; Akihiro Mori; Itaru Yoshimura; Hidekazu Koyama
Journal:  J Vet Med Sci       Date:  2016-05-07       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.